HOME  |  CONTACT US  |  SUBSCRIBE  |  SUPPORT WLF

Publication Detail


Penalty Disparities Frustrate Protection of Consumers from Dangerous Counterfeit and Diverted Drugs
Topic: Health Care
By Sheldon Bradshaw, a Partner in the FDA and Life Sciences Practice Groups at King & Spalding LLP in Washington, DC, who served as FDA Chief Counsel from 2005-2007. 
Legal Backgrounder, March 24, 2017, 4 pages
Download a PDF of the Publication
Publication Summary:

Two minor, targeted changes to the federal drug distribution law can enhance government officials’ efforts to prosecute internet pharmacies and other distributors of unapproved medical products.
  • Welcome to the Washington Legal Foundation
  • 2009 Massachusetts Ave., NW
    Washington, DC 20036
  • info@wlf.org  |  ph. 202-588-0302
    ©2017 WLF All Rights Reserved